Owner University of Washington PhaseRx, Inc.

Inventors Prieve, Mary G.; Johnson, Paul H.; Stayton, Patrick S.; Hoffman, Allan S.; Overell, Robert W.; Gall, Anna S.; Paschal, Amber E. E.; Diab, Charbel; De, Priyadarsi; Declue, Michael S.; Monahan, Sean D.

Agent Spruson & Ferguson

Pub. Number AU-A-2009313358

PCT Pub. Number WO2010/054266

Priority 61/140,774 24.12.08 US; 61/243,898 18.09.09 US; 61/171,358 21.04.09 US; 61/177,921 13.05.09 US; 61/140,779 24.12.08 US; 61/112,048 06.11.08 US; 61/112,054 06.11.08 US; 61/171,369 21.04.09 US

Filing date 6 November 2009

Wipo publication date 14 May 2010

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

C08F 212/06 (2006.01) Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by an aromatic carbocyclic ring

C08F 220/18 (2006.01) Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride, ester, amide, imide, or nitrile thereof

C08F 220/56 (2006.01) Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride, ester, amide, imide, or nitrile thereof

C08F 297/00 (2006.01) Macromolecular compounds obtained by successively polymerising different monomer systems using a catalyst of the ionic or coordination type without deactivating the intermediate polymer